Preclinical evaluation and first-in-human study of [18F]AlF-FAP-NUR for PET imaging cancer-associated fibroblasts

Shaoyu Liu,Ziqi Zhang,Jiawei Zhong,Huizhen Zhong,Yimin Fu,Lifang Liu,Xiaoting Ye,Xinlu Wang

DOI: https://doi.org/10.1186/s13550-024-01139-w

IF: 3.434

2024-10-02

EJNMMI Research

Abstract:Fibroblast activation protein (FAP) has gained attention as a promising molecular target with potential utility for cancer diagnosis and therapy. [ 68 Ga]Ga-labeled FAP-targeting peptides have been successfully applied to positron emission tomography (PET) imaging of various tumor types. To meet the applicable demand for peptide-based FAP tracers with high patient throughput, we herein report the radiosynthesis, preclinical evaluation, and the first-in-human imaging of a novel [ 18 F]F-labeled FAP-targeting peptide.

radiology, nuclear medicine & medical imaging